Shares of Amedisys Inc (AMED) rallied 12 percent to $33.03 per share during the Tuesday morning trading session. Analysts at Deutsche Bank (DB) upgraded the company from “Hold” to “Buy with a $39 price target (previous $31).” The volume of AMED shares traded was higher than normal. More than 700,000 shares have already traded hands compared to a daily average of around 528,000. Amedisys’ PEG ratio is 0.49 ; t/12 EPS is $4.51. Short interest stands at 20.60% (that’s a lot).
The morning’s trading range for shares of AMED has been between $31.30 and $33.32 per share. AMED’s shares closed at $29.23 yesterday.
At last check, Amedisys shares were up $2.71 to $31.94, a gain of 9.34%.
Disclosure: No Position